Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic diagnosis of systemic autoinflammatory diseases and underlying primary immunodeficiency

  • Seung Hwan Oh (Department of Laboratory Medicine, Pusan National University Yangsan Hospital)
  • Received : 2022.11.29
  • Accepted : 2022.12.17
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Systemic autoinflammatory diseases (SAIDs) are characterized by unprovoked inflammatory episodes such as recurrent/periodic fever, serositis, skin lesions, abdominal symptoms, arthritis/arthralgia, and central nervous system involvement. Genetic diagnosis of SAIDs has been challenging because disease manifestations overlap among themselves and with other immunological disease categories, such as infection and autoimmune diseases. However, the advent of next-generation sequencing (NGS) technologies and expanding knowledge about the innate immunity and inflammation have made the routine genetic diagnosis of SAIDs possible. Here, we review the recurrent/periodic fevers, other recently identified autoinflammatory diseases, and type I interferonopathies, and discuss the clinical usefulness of NGS targeted sequencing for SAIDs, and recent advance of understandings for this heterogeneous disease group as for underlying primary immunodeficiency.

Keywords

Acknowledgement

This study was supported by a 2021 research grant from Pusan National University Yangsan Hospital.

References

  1. Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G. Autoinflammatory diseases: state of the art. Presse Med 2019;48(1 Pt 2):e25-48. https://doi.org/10.1016/j.lpm.2018.12.003
  2. Georgin-Lavialle S, Savey L, Grateau G. Autoinflammatory syndromes. Presse Med 2019;48(1 Pt 2):e21-3. https://doi.org/10.1016/j.lpm.2018.12.005
  3. Sanchez GA, de Jesus AA, Goldbach-Mansky R. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am 2013;39:701-34. https://doi.org/10.1016/j.rdc.2013.08.001
  4. Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004;24:194-8. https://doi.org/10.1002/humu.20080
  5. Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol 2017;18:832-42. Erratum in: Nat Immunol 2017;18:1271.
  6. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, et al.; European Molecular Genetics Quality Network. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 2012;71:1599-605. https://doi.org/10.1136/annrheumdis-2011-201271
  7. Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Kone-Paut I, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 2012;71:1177-82. https://doi.org/10.1136/annrheumdis-2011-200549
  8. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016;75:644-51. https://doi.org/10.1136/annrheumdis-2015-208690
  9. Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, et al. Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 2011;128:e152-9. https://doi.org/10.1542/peds.2010-3639
  10. Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P, et al. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology (Oxford) 2012;51:1855-9. https://doi.org/10.1093/rheumatology/kes097
  11. Musters A, Tak PP, Baeten DL, Tas SW. Anti-interleukin 6 receptor therapy for hyper-IgD syndrome. BMJ Case Rep 2015;2015:bcr2015210513.
  12. Ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013;72:678-85. https://doi.org/10.1136/annrheumdis-2011-201268
  13. van der Hilst JCH, Bodar EJ, Barron KS, Frenkel J, Drenth JPH, van der Meer JWM, et al.; International HIDS Study Group. Long-term followup, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 2008;87:301-10. https://doi.org/10.1097/MD.0b013e318190cfb7
  14. Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 2017;76:1648-56. Erratum in: Ann Rheum Dis 2019;78:e73.
  15. Hashem H, Kelly SJ, Ganson NJ, Hershfield MS. Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders. Curr Rheumatol Rep 2017;19:70.
  16. Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, et al. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet 2018;26:960-71. https://doi.org/10.1038/s41431-018-0130-6
  17. Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L. Autoinflammatory granulomatous diseases: from Blau syndrome and earlyonset sarcoidosis to NOD2-mediated disease and Crohn's disease. RMD Open 2015;1:e000097.
  18. Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J 2014;12:33.
  19. Hashmi SK, Bergstrom K, Bertuch AA, Despotovic JM, Muscal E, Xia F, et al. PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome: a rare cause of childhood neutropenia associated with systemic inflammation and hyperzincemia. Pediatr Blood Cancer 2019;66:e27439.
  20. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002;11:961-9.
  21. Shigemura T, Kaneko N, Kobayashi N, Kobayashi K, Takeuchi Y, Nakano N, et al. Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behcet's disease. RMD Open 2016;2:e000223.
  22. Shinar Y, Ceccherini I, Rowczenio D, Aksentijevich I, Arostegui J, BenChetrit E, et al. ISSAID/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the nextgeneration sequencing era. Clin Chem 2020;66:525-36. https://doi.org/10.1093/clinchem/hvaa024
  23. Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsuf-ficiency cause an early-onset autoinflammatory disease. Nat Genet 2016;48:67-73.
  24. Notarangelo LD, Bacchetta R, Casanova JL, Su HC. Human inborn errors of immunity: an expanding universe. Sci Immunol 2020;5:eabb1662.
  25. Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol 2022;22:471-83.
  26. Lee JH, Kim JH, Shim JO, Lee KC, Lee JW, Lee JH, et al. Familial Mediterranean fever presenting as fever of unknown origin in Korea. Korean J Pediatr 2016;59(Suppl 1):S53-6. https://doi.org/10.3345/kjp.2016.59.11.S53
  27. Yang JA, Choi JY, Kang EH, Ha YJ, Lee YJ, Song YW. Clinical and genetic features of Korean patients with recurrent fever and multi-system inflammation without infectious or autoimmune evidence. J Korean Med Sci 2016;31:196-201.
  28. Holzinger D, Fassl SK, de Jager W, Lohse P, Rohrig UF, Gattorno M, et al. Single amino acid charge switch defines clinically distinct prolineserine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. J Allergy Clin Immunol 2015;136:1337- 45. https://doi.org/10.1016/j.jaci.2015.04.016
  29. Jo KJ, Park SE, Cheon CK, Oh SH, Kim SH. Haploinsufficiency A20 misdiagnosed as PFAPA syndrome with Kikuchi disease. Clin Exp Pediatr 2022, in press.
  30. Liang J, Zhang H, Guo Y, Yang K, Ni C, Yu H, et al. Coinheritance of generalized pustular psoriasis and familial Behcet-like autoinflammatory syndrome with variants in IL36RN and TNFAIP3 in the heterozygous state. J Dermatol 2019;46:907-10. https://doi.org/10.1111/1346-8138.15034
  31. Frenkel J, van Kempen MJ, Kuis W, van Amstel HK. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1. Arthritis Rheum 2004;50:2719-20. https://doi.org/10.1002/art.20295
  32. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, et al. MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol 2008;26:13-7.